HYPOTHYROIDISM
CLASSIFICATION
ETIOLOGICAL
PRIMARY
TRANSIENTSECONDARY
pathogenesis
Causes
PRIMARY
1) Congenital
 Agenesis
 Ectopic thyroid remnants
2) Defects of hormone synthesis
 Iodine deficiency
 Dyshormonogenesis
 Drugs -Antithyroid drugs, lithium,
amiodarone, interferon)
3)Autoimmune
 Atrophic thyroiditis
 Hashimoto's thyroiditis
 Postpartum thyroiditis
4) Infective
 Post-subacute thyroiditis
5) Post-surgery
6) Post-irradiation
 Radioactive iodine therapy
 External neck irradiation
7) Infiltration
 Tumour
SECONDARY
1) Hypopituitarism
2) Isolated TSH deficiency
3) Peripheral resistance to thyroid hormone
 Hypothyroidism may be due to primary disease of the thyroid gland(primary) or due to lack of
pituitary TSH(secondary)
Clinical features
EVALUATION OF HYPOTHYROIDISM
investigations
 Classical findings of primary hypothyroidism are reduced levels of
T3 and T4 and increased levels of TSH.
 Secondary hypothyroidism T3, T4, TSH all are reduced, along with
other pituitary hormones.
 Other abnormal investigations are
 Anemia –macrocytic or microcytic (mennoraghia).
 ECG-- bradycardia, low voltage complexes.
 Increase in CK from muscle.
 Hypercholesterolemia.
 Antibodies to thyroid peroxidase are positive in spontaneous
atrophic thyroiditis and hashimoto’s thyroiditis.
treatment
• DRUG OF CHOICE: thyroxine
• Drug should be taken 30 minutes before a meal
• Dose depends on:
a) severity of deficiency
b) Age of patient
c) Fitness of patient
• INITIATION OF THERAPY:
 Based on age
 Young and middle aged adults:100
mcg daily
 Healthy elderly: 50 mcg daily
 With cardiac disease: 25-50 mcg daily
 Based on severity of disease
 Clinical hypothyroidism
i. No residual thyroid function: 100-150
mcg/d
ii. Underlying autonomous function of gland
is present: 75-125mcg/d
 Subclinical hypothyroidism:
• This term is used when TSH is elevated
(>10microUnits per litre) and T3, T4 are normal
with vague symptoms.
• This condition should be treated only if there are
• High titers of antibodies
• Lipid abnormalities
• Associated with goiter
• If above indications are not present then patient
should be followed up with TSH andT3, T4 every
3-6 months.
 DOSE: 25-50 microgram/d
Subclinical hypothyroidism
• DOSE ADUSTMENT AND FOLLOW-UP
 Primary hypothyroidism:
 GOAL-maintain plasma TSH within normal
range
 Plasma TSH is measured 6-8 weeks after
initiation of therapy
 Dose is adjusted in 12-25 mcg increments at 6-
8 week intervals till plasma TSH is normal
 Annual TSH measurement is adequate
thereafter
 Overcorrection of TSH levels will increase the
risk of atrial fibrillation and osteoporosis
 Secondary hypothyroidism
 GOAL: maintain plasma free T4 levels near the
upper limit of the reference range
 Dose is adjusted in 12-25 mcg increments a 6-8
week intervals till plasma TSH is normal
 Annual TSH measurement is adequate
thereafter
 Subclinical hypothyroidism
 Goal:normalise TSH
 Annual evaluation if not treated
MYXOEDEMA COMA
 Myxedema coma is a medical emergency.
 Commonly seen in elderly patients with longstanding
hypothyroidism.
 Common precipitating factors are sedatives , anaesthetics,
pneumonia,CCF, MI, GI bleed, CVA
 Mortality rates are 50%
 Clinical manifestations:
 Hypothermia
 Altered consciousness- result of delayed cerebration .
 Hypoventilation -
 Bradycardia
 Hypoglycemia and SIADH.
Management
 Levothyroxine (T4)
loading dose.:500mcg I.V. bolus
continued at a dose of 50 to 100 mcg/d.
.
 alternative :
liothyronine (T3) :10 to 25 mcg every 8 to
12h .
 Inj. Hydrocortisone 50mg I.V 6hrly should be
given and can be stopped if cortisol levels are
normal.
 Other measures include:
---Oxygen and gradual rewarming.
---Glucose and sodium correction.
---Ventilatory support if required.
• Medication blood levels should be monitored, when
avavilable, to guide dosage.
THYROIDITIS
 Thyroiditis most often results from an infective or
autoimmune process
Classification of thyroiditis
 Acute thyroiditis - Bacterial, viral,
 Subacute thyroiditis - de Quervain's thyroiditis
 Chronic thyroiditis - Autoimmune - Hashimoto’s
(chronic lymphocytic), Riedel thyroiditis
HASHIMOTO’S THYROIDITIS
 It is autoimmune thyroiditis.
 Common in middle aged females.
 Histologically, there is marked lymphocytic
infiltration to the extent of formation of
germinal centers. Askanazy cells are present.
 Gland is diffusely enlarged and is firm.
 Patient may be euthyroid or hypothyroid.
 AntiTPO Ab is positive and thyroid scan
uptake is low.
 Treatment is required only if there is
hypothyroidism or goiter.
Non thyroidal illnesses
T4 to T3 and binding to TBG
TFT: low T3
Normal T4
Normal TSH
THE SICK EUTHYROID SYNDROME

Hypothyroidism

  • 1.
  • 2.
  • 3.
  • 4.
    Causes PRIMARY 1) Congenital  Agenesis Ectopic thyroid remnants 2) Defects of hormone synthesis  Iodine deficiency  Dyshormonogenesis  Drugs -Antithyroid drugs, lithium, amiodarone, interferon) 3)Autoimmune  Atrophic thyroiditis  Hashimoto's thyroiditis  Postpartum thyroiditis 4) Infective  Post-subacute thyroiditis 5) Post-surgery 6) Post-irradiation  Radioactive iodine therapy  External neck irradiation 7) Infiltration  Tumour SECONDARY 1) Hypopituitarism 2) Isolated TSH deficiency 3) Peripheral resistance to thyroid hormone  Hypothyroidism may be due to primary disease of the thyroid gland(primary) or due to lack of pituitary TSH(secondary)
  • 5.
  • 6.
  • 7.
    investigations  Classical findingsof primary hypothyroidism are reduced levels of T3 and T4 and increased levels of TSH.  Secondary hypothyroidism T3, T4, TSH all are reduced, along with other pituitary hormones.  Other abnormal investigations are  Anemia –macrocytic or microcytic (mennoraghia).  ECG-- bradycardia, low voltage complexes.  Increase in CK from muscle.  Hypercholesterolemia.  Antibodies to thyroid peroxidase are positive in spontaneous atrophic thyroiditis and hashimoto’s thyroiditis.
  • 8.
    treatment • DRUG OFCHOICE: thyroxine • Drug should be taken 30 minutes before a meal • Dose depends on: a) severity of deficiency b) Age of patient c) Fitness of patient
  • 9.
    • INITIATION OFTHERAPY:  Based on age  Young and middle aged adults:100 mcg daily  Healthy elderly: 50 mcg daily  With cardiac disease: 25-50 mcg daily
  • 10.
     Based onseverity of disease  Clinical hypothyroidism i. No residual thyroid function: 100-150 mcg/d ii. Underlying autonomous function of gland is present: 75-125mcg/d  Subclinical hypothyroidism:
  • 11.
    • This termis used when TSH is elevated (>10microUnits per litre) and T3, T4 are normal with vague symptoms. • This condition should be treated only if there are • High titers of antibodies • Lipid abnormalities • Associated with goiter • If above indications are not present then patient should be followed up with TSH andT3, T4 every 3-6 months.  DOSE: 25-50 microgram/d Subclinical hypothyroidism
  • 12.
    • DOSE ADUSTMENTAND FOLLOW-UP  Primary hypothyroidism:  GOAL-maintain plasma TSH within normal range  Plasma TSH is measured 6-8 weeks after initiation of therapy  Dose is adjusted in 12-25 mcg increments at 6- 8 week intervals till plasma TSH is normal  Annual TSH measurement is adequate thereafter  Overcorrection of TSH levels will increase the risk of atrial fibrillation and osteoporosis
  • 13.
     Secondary hypothyroidism GOAL: maintain plasma free T4 levels near the upper limit of the reference range  Dose is adjusted in 12-25 mcg increments a 6-8 week intervals till plasma TSH is normal  Annual TSH measurement is adequate thereafter  Subclinical hypothyroidism  Goal:normalise TSH  Annual evaluation if not treated
  • 14.
    MYXOEDEMA COMA  Myxedemacoma is a medical emergency.  Commonly seen in elderly patients with longstanding hypothyroidism.  Common precipitating factors are sedatives , anaesthetics, pneumonia,CCF, MI, GI bleed, CVA  Mortality rates are 50%
  • 15.
     Clinical manifestations: Hypothermia  Altered consciousness- result of delayed cerebration .  Hypoventilation -  Bradycardia  Hypoglycemia and SIADH.
  • 16.
    Management  Levothyroxine (T4) loadingdose.:500mcg I.V. bolus continued at a dose of 50 to 100 mcg/d. .  alternative : liothyronine (T3) :10 to 25 mcg every 8 to 12h .  Inj. Hydrocortisone 50mg I.V 6hrly should be given and can be stopped if cortisol levels are normal.
  • 17.
     Other measuresinclude: ---Oxygen and gradual rewarming. ---Glucose and sodium correction. ---Ventilatory support if required. • Medication blood levels should be monitored, when avavilable, to guide dosage.
  • 18.
    THYROIDITIS  Thyroiditis mostoften results from an infective or autoimmune process Classification of thyroiditis  Acute thyroiditis - Bacterial, viral,  Subacute thyroiditis - de Quervain's thyroiditis  Chronic thyroiditis - Autoimmune - Hashimoto’s (chronic lymphocytic), Riedel thyroiditis
  • 19.
    HASHIMOTO’S THYROIDITIS  Itis autoimmune thyroiditis.  Common in middle aged females.  Histologically, there is marked lymphocytic infiltration to the extent of formation of germinal centers. Askanazy cells are present.  Gland is diffusely enlarged and is firm.  Patient may be euthyroid or hypothyroid.  AntiTPO Ab is positive and thyroid scan uptake is low.  Treatment is required only if there is hypothyroidism or goiter.
  • 20.
    Non thyroidal illnesses T4to T3 and binding to TBG TFT: low T3 Normal T4 Normal TSH THE SICK EUTHYROID SYNDROME